DK1626726T3 - Anvendelse af lornoxicam eller lornoxicam-analoger - Google Patents
Anvendelse af lornoxicam eller lornoxicam-analogerInfo
- Publication number
- DK1626726T3 DK1626726T3 DK04734972T DK04734972T DK1626726T3 DK 1626726 T3 DK1626726 T3 DK 1626726T3 DK 04734972 T DK04734972 T DK 04734972T DK 04734972 T DK04734972 T DK 04734972T DK 1626726 T3 DK1626726 T3 DK 1626726T3
- Authority
- DK
- Denmark
- Prior art keywords
- lornoxicam
- analogues
- oxygenase
- cox
- cyclo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0081903A AT413944B (de) | 2003-05-27 | 2003-05-27 | Verwendung von oxicam-verbindungen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1626726T3 true DK1626726T3 (da) | 2006-12-27 |
Family
ID=33479909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04734972T DK1626726T3 (da) | 2003-05-27 | 2004-05-27 | Anvendelse af lornoxicam eller lornoxicam-analoger |
Country Status (13)
Country | Link |
---|---|
US (2) | US8129370B2 (da) |
EP (1) | EP1626726B1 (da) |
JP (1) | JP5597339B2 (da) |
KR (1) | KR101134244B1 (da) |
CN (3) | CN102218067A (da) |
AT (2) | AT413944B (da) |
CA (1) | CA2526816C (da) |
DE (1) | DE502004001499D1 (da) |
DK (1) | DK1626726T3 (da) |
ES (1) | ES2271893T3 (da) |
PL (1) | PL1626726T3 (da) |
RU (1) | RU2366425C2 (da) |
WO (1) | WO2004105766A2 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005238220A1 (en) * | 2004-04-29 | 2005-11-10 | Binder, Eva | Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
CA2742771A1 (en) * | 2008-11-13 | 2010-05-20 | Modgene, Llc | Modification of amyloid-beta load in non-brain tissue |
US9707231B2 (en) | 2011-11-01 | 2017-07-18 | Modgene, Llc | Compositions and methods for reduction of amyloid-beta load |
CN115227655A (zh) * | 2022-08-17 | 2022-10-25 | 海南锦瑞制药有限公司 | 注射用氯诺昔康的制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU518216B2 (en) * | 1977-09-06 | 1981-09-17 | Hafslund Nycomed Pharma Aktiengesellschaft | Thienothiazine derivatives |
JPS58146040A (ja) * | 1982-02-24 | 1983-08-31 | Pioneer Video Kk | 光学式情報記録原盤 |
EP0103142B1 (de) * | 1982-09-09 | 1987-04-22 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Thieno(2,3-e)-1,2-thiazin-Derivate |
NZ226477A (en) * | 1987-10-29 | 1990-07-26 | Cl Pharma | Substituted thieno (2,3-e)-1,2 thiazine derivatives and pharmaceutical compositions |
US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
AT400437B (de) * | 1993-12-14 | 1995-12-27 | Chem Pharm Forsch Gmbh | Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung |
US5643960A (en) * | 1994-04-15 | 1997-07-01 | Duke University | Method of delaying onset of alzheimer's disease symptoms |
EP1006798A4 (en) * | 1996-09-05 | 2003-03-05 | Massachusetts Inst Technology | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES |
US6184248B1 (en) * | 1996-09-05 | 2001-02-06 | Robert K. K. Lee | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
EP1216037A2 (en) * | 1999-09-21 | 2002-06-26 | Emory University | Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
US6429223B1 (en) * | 2000-06-23 | 2002-08-06 | Medinox, Inc. | Modified forms of pharmacologically active agents and uses therefor |
TWI256305B (en) * | 2000-08-18 | 2006-06-11 | Pharmacia Corp | Oral fast-melt pharmaceutical composition of a cyclooxygenase-2 inhibitor and process for preparing the same |
JP2002363104A (ja) | 2001-04-04 | 2002-12-18 | Sankyo Co Ltd | 炎症性サイトカイン産生抑制剤の新規医薬用途 |
ATE375173T1 (de) * | 2001-08-20 | 2007-10-15 | Fujifilm Corp | Hydrophobe iodverbindung enthaltendes liposom und dieses enthaltendes röntgenkontrastmittel |
US20030225054A1 (en) * | 2002-06-03 | 2003-12-04 | Jingwu Duan | Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents |
-
2003
- 2003-05-27 AT AT0081903A patent/AT413944B/de not_active IP Right Cessation
-
2004
- 2004-05-27 ES ES04734972T patent/ES2271893T3/es active Active
- 2004-05-27 PL PL04734972T patent/PL1626726T3/pl unknown
- 2004-05-27 US US10/558,117 patent/US8129370B2/en not_active Expired - Fee Related
- 2004-05-27 DK DK04734972T patent/DK1626726T3/da active
- 2004-05-27 DE DE502004001499T patent/DE502004001499D1/de active Active
- 2004-05-27 KR KR1020057022636A patent/KR101134244B1/ko active IP Right Grant
- 2004-05-27 CA CA2526816A patent/CA2526816C/en not_active Expired - Fee Related
- 2004-05-27 AT AT04734972T patent/ATE339206T1/de active
- 2004-05-27 JP JP2006529424A patent/JP5597339B2/ja not_active Expired - Fee Related
- 2004-05-27 RU RU2005136864/15A patent/RU2366425C2/ru not_active IP Right Cessation
- 2004-05-27 WO PCT/AT2004/000185 patent/WO2004105766A2/de active Application Filing
- 2004-05-27 EP EP04734972A patent/EP1626726B1/de not_active Expired - Fee Related
- 2004-05-27 CN CN2011100997401A patent/CN102218067A/zh active Pending
- 2004-05-27 CN CNA2008101754015A patent/CN101450057A/zh active Pending
- 2004-05-27 CN CNA2004800143442A patent/CN1842338A/zh active Pending
-
2009
- 2009-04-03 US US12/418,339 patent/US20090239852A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR101134244B1 (ko) | 2012-04-09 |
JP2006528206A (ja) | 2006-12-14 |
RU2005136864A (ru) | 2006-06-10 |
ES2271893T3 (es) | 2007-04-16 |
ATA8192003A (de) | 2005-11-15 |
DE502004001499D1 (de) | 2006-10-26 |
RU2366425C2 (ru) | 2009-09-10 |
WO2004105766A2 (de) | 2004-12-09 |
CA2526816A1 (en) | 2004-12-09 |
PL1626726T3 (pl) | 2007-02-28 |
US20090239852A1 (en) | 2009-09-24 |
KR20060017618A (ko) | 2006-02-24 |
JP5597339B2 (ja) | 2014-10-01 |
WO2004105766A3 (de) | 2005-03-03 |
CN102218067A (zh) | 2011-10-19 |
ATE339206T1 (de) | 2006-10-15 |
AT413944B (de) | 2006-07-15 |
US20070275958A1 (en) | 2007-11-29 |
CN101450057A (zh) | 2009-06-10 |
EP1626726A2 (de) | 2006-02-22 |
US8129370B2 (en) | 2012-03-06 |
CA2526816C (en) | 2012-11-27 |
CN1842338A (zh) | 2006-10-04 |
EP1626726B1 (de) | 2006-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113766T1 (el) | Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων | |
CY1115719T1 (el) | Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων | |
CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
CY1108843T1 (el) | 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων | |
EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
CY1111567T1 (el) | Ενδιαμεσα διβενζο (b,f) αζεπινης | |
TNSN06012A1 (en) | Emulsifying systems containing azetidine derivatives | |
PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
DE502004011919D1 (de) | -trien-3-yl sulfamate | |
DK1626726T3 (da) | Anvendelse af lornoxicam eller lornoxicam-analoger | |
MXPA06000636A (es) | Formulaciones semi-solidas para la administracion oral de taxoides. | |
EA200600998A1 (ru) | Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза | |
CY1106129T1 (el) | Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος | |
EA201000739A1 (ru) | Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата | |
ITRM20000433A0 (it) | Uso di fibrati per la preparazione di un medicamento utile nel trattamento dell'insufficenza cardiaca congestizia. | |
HUP0300032A2 (en) | Use of compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoreceptor for preparation of pharmaceutical composition | |
DE60216090D1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia |